10468 Inorganic Chemistry, Vol. 48, No. 21, 2009
Geier et al.
3
3
(t, 1F, JF-F=23 Hz, m-C6F5), -162.9 (t,1F, JF-F = 23 Hz,
m-C6F5), -164.5 (br s, 2F, m-C6F5), -165.1 (br m, 1F, m-C6F5),
-165.6 (br s, 1F, m-C6F5), 11B NMR (CDCl3): -2.9; 13C NMR
(CDCl3) (partial): 124.3, 128.0, 128.5, 129.8, 131.6, 142.3, 148.5.
Calcd for C29H9BF15N: C, 52.21%; H, 1.36%; N, 2.10%. Found:
C, 51.77%; H, 1.71%; N, 2.32%.
3JH-H = 7 Hz), 8.65 (br s, 1H, pyridinium N-H); 19F NMR
3
(CDCl3): -133.7 (d, JF-F = 20 Hz, 6F, o-C6F5), -157.0 (t,
3JF-F = 19 Hz, 3F, p-C6F5), -163.0 (br s, 6F, m-C6F5); 11B
NMR (CDCl3): -11.1; 13C NMR (CDCl3) (partial): 19.3,
1
109.5, 114.5, 137.0 (dm, JC-F = 256 Hz, CF), 141.8, 142.3
(dm, 1JC-F = 242 Hz, CF), 148.1 (dm, 1JC-F = 240 Hz, CF),
155.2. Anal. Calcd for C24H8BF15N2: C, 46.48%; H, 1.30%; N,
4.52%. Found: C, 46.30%; H, 1.18%; N, 5.02%.
5. Yield: 79%. Crystals were grown from toluene at -35 °C.
1H NMR (CD2Cl2): 6.68 (d, JH-H = 8 Hz, 1H), 7.16 (ddd,
3
3JH-H = 8 Hz, 3JH-H=5 Hz, 4JH-H = 1 Hz, 1H), 7.43-7.48 (ov
m, 2H), 7.72 (ddd, 3JH-H = 8 Hz, 3JH-H = 6 Hz, 4JH-H=2 Hz,
1H), 8.17 (ddd, 3JH-H = 5 Hz, 4JH-H = 2 Hz, 4JH-H=1 Hz,
1H), 8.23 (td, 3JH-H =8 Hz, 4JH-H = 2 Hz, 1H), 8.82 (br s, 1H) ;
19F NMR (CD2Cl2): -125.2 (m, 1F, o-C6F5), -130.9 (m, 1F,
o-C6F5), -131.5 (m, 1F, o-C6F5), -133.1 (m, 2F, o-C6F5), -135.6
(d, 3JF-F = 21 Hz, 1F, o-C6F5), -156.7 (t, 3JF-F = 19 Hz, 1F,
p-C6F5), -158.3 (m, 1F, p-C6F5), -160.0 (t, 3JF-F = 21 Hz, 1F,
p-C6F5), -160.5 (m, 1F, m-C6F5), -163.3 (t, 3JF-F = 21 Hz, 1F,
Synthesis of (2,6-Me2C5H3N)B(C6F5)3 9. B(C6F5)3 (100 mg,
0.20 mmol) was added to 2,6-lutidine (21 mg, 0.20 mmol) in
2 mL of toluene. The solution was allowed to stir for 4 h and
2 mL of pentane was added. The solution was stored at -35 °C.
X-ray quality crystals precipitated from solution and were washed
with pentane (2 ꢀ 2 mL) and again pumped to dryness. Yield:
1
60 mg (51%). NMR data were acquired at -10 °C. H NMR
3
(CD2Cl2): 2.58 (s, CH3), 7.36 (d, 2H, JH-H = 8 Hz, m-CH),
7.89 (t, 1H, 3JH-H = 8 Hz, p-CH); 19F NMR (CD2Cl2): -131.4
(br s, 2F, o-C6F5), -132.4 (br s, 2F, o-C6F5), -133.0 (d, 2F,
3JF-F = 18 Hz, o-C6F5), -157.6 (t, 1F, 3JF-F = 20 Hz, p-C6F5),
3
m-C6F5), -163.8 (t, JF-F = 21 Hz, 1F, m-C6F5), -166.0 (t,
3JF-F = 20 Hz, 1F, m-C6F5), -166.5 (m, 1F, m-C6F5), -167.6
(m, 1F, m-C6F5); 11B NMR (CD2Cl2): -2.7; 13C NMR (CDCl3)
(partial): 123.7, 124.0, 125.0, 130.8, 136.4, 142.8, 148.5, 149.3,
153.6, 158.9. Calcd for C28H8BF15N2: C, 50.33%; H, 1.21%; N,
4.19%. Found: C, 49.87%; H, 1.44%; N, 4.32%.
-158.7 (t, 2F, 3JF-F = 20 Hz, p-C6F5), -164.4 (t, 2F, 3JF-F
=
21 Hz, m-C6F5), -165.2 (m, 4F, m-C6F5); 11B NMR (CD2Cl2):
-3.9. Anal. Calcd for C31H17BF15NO4: C, 48.50%; H, 1.47%;
N, 2.26%. Found: C, 48.70%; H, 1.85%; N, 2.23%.
6. Yield: 96%. 1H NMR (CDCl3): 7.77 (m, 2H), 7.84 (m, 1H),
8.09 (dd, 3JH-H = 8 Hz, 4JH-H = 2 Hz, 1H), 8.51 (d, 3JH-H = 9
Hz, 1H), 8.72 (d, 3JH-H=8 Hz, 1H), 9.19 (q, 3JH-H = 5 Hz, 1H);
Synthesis of [2,6-Me2C5H3NH][HB(C6F5)3] 10, [(2,6-Ph2)-
C5H3NH][HB(C6F5)3] 11, [(2-tBu)C5H4NH][HB(C6F5)3] 12.
These compounds were prepared in a similar fashion and thus
only one preparation is detailed. B(C6F5)3 (100 mg, 0.20 mmol)
was added to of 2,6-lutidine (21 mg, 0.20 mmol) in 10 mL of
toluene. The solution was subjected to 3 freeze-pump-thaw
cycles and backfilled with H2 at 77 K (∼4 atm). The solution was
allowed to stir overnight at room temperature and then pumped
to dryness. The solid was washed with pentane (2 ꢀ 2 mL) and
again pumped to dryness.
3
19F NMR (CDCl3): -126.6 (m, JF-F = 27 Hz, 1F, o-C6F5),
-128.8 (br m, 1F, o-C6F5), -131.9 (br m, 1F, o-C6F5), -132.9
3
(m, JF-F = 36 Hz, 1F, o-C6F5), -133.3 (br m, 1F, o-C6F5),
3
4
-133.7 (m, 1F, o-C6F5), -155.1 (tt, JF-F = 20 Hz, JF-F
=
4 Hz, 1F, p-C6F5), -156.2 (tt, 3JF-F = 20 Hz, 4JF-F = 3 Hz, 1F,
p-C6F5), -157.2 (tt, 3JF-F =20 Hz, 4JF-F = 3 Hz, 1F, p-C6F5),
-161.2 (td, 3JF-F = 21 Hz, 4JF-F = 8 Hz, 1F, m-C6F5), -162.3
(td, 3JF-F = 23 Hz, 4JF-F = 10 Hz, 1F, m-C6F5), -163.2 (td,
10. Yield: 105 mg (87%). X-ray quality crystals were grown
by slow evaporation of a toluene solution. 1H NMR (CD2-
Cl2): 2.61 (s, 6H, CH3), 3.55 (q, 1JB-H = 88 Hz, B-H), 7.53 (d,
3JH-H = 8 Hz, 2H, m-CH), 8.22 (t, 1H, 3JH-H = 8 Hz, p-CH),
12.01 (br s, 1H, N-H); 19F NMR (CD2Cl2): -136.8 (br d, 6F,
3JF-F = 18 Hz, o-C6F5), -165.8 (t, 3F 3JF-F = 20 Hz, p-C6F5),
-169.3 (br t, 6F, 3JF-F = 20 Hz, m-C6F5); 11B NMR (CD2Cl2):
-24.7 (d, 1JB-H = 88 Hz); 13C NMR (CD2Cl2) (partial): 19.9,
125.5, 136.7 (dm, 1JC-F = 245 Hz CF), 138.4 (dm, 1JC-F = 249
Hz, CF), 147.2, 148.2, (dm, 1JC-F = 238 Hz, CF), 153.8. Anal.
Calcd for C26H11BF15N: C, 48.34%; H, 1.78%; N, 2.25%.
Found: C, 48.49%; H, 2.06%; N, 2.43%.
3JF-F = 22 Hz, 4JF-F=8 Hz, 1F, m-C6F5), -163.7 (td, 3JF-F
=
4
22 Hz, JF-F = 9 Hz, 1F, m-C6F5), -163.8 (m, peaks over-
lapping, m-C6F5), -163.9 (m, peaks overlapping, 1F, m-C6F5);
11B NMR (CDCl3): -3.2; 13C NMR (CDCl3) (partial): 120.2,
122.4, 128.6, 129.6, 130.1, 133.1, 142.6, 145.0, 150.4, C27H7-
BF15N: C, 50.58%; H, 1.10%; N, 2.18%. Found: C, 50.23%; H,
0.98%; N, 2.35%.
7. Yield: 86%. X-ray quality crystals were grown by
slow evaporation from CD2Cl2. H NMR (CD2Cl2): 6.44 (d,
1
3JH-H=8 Hz, 1H), 6.96 (dd, 3JH-H=7 Hz, 3JH-H=5 Hz, 2H),
3
4
3
7.02 (td, JH-H=7 Hz, JH-H =1 Hz, 1H), 7.55 (td, JH-H
8 Hz, 4JH-H = 2 Hz, 1H), 7.67 (br s, NH), 7.91 (ddd, 3JH-H
=
=
11. Yield: 82%. X-ray quality crystals were grown from
dichloromethane. 1H NMR (CD2Cl2): 3.35 (q, 1JB-H=92 Hz,
B-H), 7.57-7.62 (m, 4H), 7.64-7.68 (m, 2H), 7.74-7.77 (m,
4H), 8.05 (d, 3JH-H = 8 Hz, 2H, m-CH), 8.51 (t, 3JH-H = 8 Hz,
1H, p-CH), 11.27 (br s, 1H, N-H); 19F NMR (CD2Cl2): -134.3
(br d, 3JF-F = 21 Hz, 6F, o-C6F5), -164.8 (t, 3JF-F = 20 Hz,
9 Hz, 3JH-H = 7 Hz, 4JH-H = 2 Hz, 1H), 8.21 (m, 2H), 8.58 (d,
3JH-H = 9 Hz, 1H); 19F NMR (CD2Cl23): -127.0 (m, 1F,
o-C6F5), -128.1 (m, 1F, o-C6F5), -131.6 (d, JF-F=23 Hz, 1F,
o-C6F5), -133.0 (m, 1F, o-C6F5); -135.7 (m, 1F, o-C6F5), -137.1
(m, 1F, o-C6F5), -157.0 (t, 3JF-F=20 Hz, 3F, p-C6F5), -163.0
3
3F, p-C6F5), -167.7 (br t, JF-F = 20 Hz, 6F, m-C6F5); 11B
3
4
(td, JF-F = 22 Hz, JF-F = 8 Hz, 1F, m-C6F5), -163.9 (tt,
NMR (CD2Cl2): -24.6 (d, 1JB-H = 92 Hz); 13C NMR (CD2Cl2)
(partial): 122.6, 126.9, 127.5, 130.2, 132.4. Anal. Calcd for
C35H15BF15N: C, 56.40%; H, 2.03%; N, 1.88%. Found: C,
56.19%; H, 2.18%; N, 2.09%.
3JF-F = 22 Hz, JF-F = 9 Hz, 2F, m-C6F5), -164.0 (td,
4
3JF-F = 21 Hz, JF-F = 7 Hz, 1F, m-C6F5), -164.2 (td,
4
3JF-F=22 Hz, JF-F = 8 Hz, 1F, m-C6F5); 11B NMR (CD2-
4
Cl2): -5.1; 13C NMR (CD2Cl2) (partial): 139.0, 142.8, 144.1 (m),
148.2, 151.2, 152.4 (m). Anal. Calcd for C28H9BF15N3: C,
49.23%; H, 1.33%; N, 6.15%. Found: C, 49.59%; H, 1.69%;
N, 6.13%.
1
12. Yield: 105 mg (83%). H NMR (CD2Cl2): 1.51 (s, 9H,
1
3
C-CH3), 3.66 (q, JB-H =88 Hz, 1H, B-H), 7.80 (t, JH-H
=
7 Hz, 1H), 7.96 (d, 3JH-H = 8 Hz, 1H), 8.45 (dd, 3JH-H = 8 Hz,
4JH-H = 2 Hz, 1H), 8.48 (d, 3JH-H = 7 Hz, 1H), 12.13 (br s, 1H,
N-H); 19F NMR (CD2Cl2): -134.7 (br d, 3JF-F = 22 Hz, 6F,
o-C6F5), -163.6 (t, 3JF-F = 21 Hz, 3F, p-C6F5), -167.1 (m, 6F,
Synthesis of (5-Me)C5H3NH(2-NH)B(C6F5)3 8. 2-Amino-6-
picoline (4.5 mg, 0.04 mmol) was added to a solution of B(C6F5)3
(20 mg, 0.039 mmol) in 2 mL of CH2Cl2. The solution was
allowed to stand for 2 h, then all volatiles were removed and the
residue was washed with pentane (2 ꢀ 2 mL). The resulting
white solid was again pumped to dryness. Yield: 23 mg (96%).
X-ray quality crystals were grown from a layered solution of
m-C6F5); 11B NMR (CD2Cl2): -24.7 (d, JB-H =87 Hz); 13C
1
NMR (CD2Cl2) (partial): 28.8, 37.1, 125.2, 125.3, 136.8 (dm,
1JC-F = 254 Hz, CF), 140.7, 147.7, 148.2 (dm, CF, 1JC-F = 240
Hz). Anal. Calcd for C27H15BF15N: C, 49.95%; H, 2.33%; N,
2.16%. Found: C, 49.76%; H, 2.22%; N, 2.06%.
1
CDCl3/pentane at room temperature. H NMR (CDCl3): 2.13
(s, 3H, CH3), 6.07 (br s, 1H, amide N-H), 6.23 (dm, 3JH-H = 7 Hz,
1H), 6.55 (br d, JH-H = 9 Hz, 1H), 7.38 (dd, JH-H=9 Hz,
X-ray Data Collection and Reduction. Crystals were coated
in Paratone-N oil in the glovebox, mounted on a MiTegen
3
3